Pharmacokinetic comparison of ginsenoside metabolite IH-901 from fermented and non-fermented ginseng in healthy Korean volunteers

Journal of Ethnopharmacology

Volumn 139, Issue 2, 2012, Pages 664-667

  Jin, Hui ^a   Seo, Ji Hyung ^b   Uhm, Yoon Kyung ^a   Jung, Chae Young ^a   Lee, Seung Kwon ^c   Yim, Sung Vin ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

^c IL HWA Co Ltd   (South Korea)

Author keywords

Clinical trial; Fermentation; Ginseng; IH 901; Pharmacokinetic

Indexed keywords

FERMENTED GINSENG EXTRACT; GINSENG EXTRACT; GINSENOSIDE; NONFERMENTED GINSENG EXTRACT; PROTOPANAXADIOL 20 GLUCOSIDE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DRUG BLOOD LEVEL; GINSENG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; KOREA; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; OPEN STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASIAN CONTINENTAL ANCESTRY GROUP; BACTERIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; FERMENTATION; HUMANS; INTESTINES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PANAX; PLANT PREPARATIONS; PLANTS, MEDICINAL; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; SAPOGENINS; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

PANAX GINSENG;

EID: 84856017054     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2011.11.052     Document Type: Article

References (9)

1. T. Akao, M. Kanaoka, and K. Kobashi Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration - measurement of compound K by enzyme immunoassay Biological and Pharmaceutical Bulletin 21 1998 245 249 (Pubitemid 28166911)
2. H. Hasegawa, J.H. Sung, and Y. Benno Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins Planta Medica 63 1997 436 440 (Pubitemid 27399983)
3. H. Hasegawa, J.H. Sung, S. Matsumiya, and M. Uchiyama Main ginseng saponin metabolites formed by intestinal bacteria Planta Medica 62 1996 453 457 (Pubitemid 26370341)
4. H. Hasegawa, K.S. Lee, T. Nagaoka, Y. Tezuka, M. Uchiyama, S. Kadota, and I. Saiki Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters Biological and Pharmaceutical Bulletin 23 2000 298 304 (Pubitemid 30187274)
5. S.J. Lee, W.G. Ko, J.H. Kim, J.H. Sung, C.K. Moon, and B.H. Lee Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease Biochemical Pharmacology 60 2000 677 685
6. S.J. Lee, J.H. Sung, S.J. Lee, C.K. Moon, and B.H. Lee Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin Cancer Letters 144 1999 39 43
7. K.H. Noh, J.W. Son, H.J. Kim, and D.K. Oh Ginsenoside compound K production from ginseng root extract by a thermostable beta-glycosidase from Sulfolobus solfataricus Bioscience, Biotechnology, and Biochemistry 73 2009 316 321
8. M.A. Tawab, U. Bahr, M. Karas, M. Wurglics, and M. Schubert-Zsilavecz Degradation of ginsenosides in humans after oral administration Drug metabolism and Disposition 31 2003 1065 1071 (Pubitemid 36975678)
9. W. Zhou, Q. Yan, J.Y. Li, X.C. Zhang, and P. Zhou Biotransformation of Panax notoginseng saponins into ginsenoside compound K production by Paecilomyces bainier sp. 229 Journal of Applied Microbiology 104 2008 699 706 (Pubitemid 351257729)